Premature ventricular contraction history and symptoms: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
(/* 2013 ESC Guideline for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death - Myocarditis, Rheumatic Disease, and Endocarditis{{cite journal|last1=Priori|first1=Silvia G.|last2=Blomström-Lundqvist|first2=Ca...)
Line 47: Line 47:
* Syncope  
* Syncope  
* Hypotension
* Hypotension
==2017 ESC Guideline for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death<ref name="Al-KhatibStevenson2018">{{cite journal|last1=Al-Khatib|first1=Sana M.|last2=Stevenson|first2=William G.|last3=Ackerman|first3=Michael J.|last4=Bryant|first4=William J.|last5=Callans|first5=David J.|last6=Curtis|first6=Anne B.|last7=Deal|first7=Barbara J.|last8=Dickfeld|first8=Timm|last9=Field|first9=Michael E.|last10=Fonarow|first10=Gregg C.|last11=Gillis|first11=Anne M.|last12=Granger|first12=Christopher B.|last13=Hammill|first13=Stephen C.|last14=Hlatky|first14=Mark A.|last15=Joglar|first15=José A.|last16=Kay|first16=G. Neal|last17=Matlock|first17=Daniel D.|last18=Myerburg|first18=Robert J.|last19=Page|first19=Richard L.|title=2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death|journal=Circulation|volume=138|issue=13|year=2018|issn=0009-7322|doi=10.1161/CIR.0000000000000549}}</ref>
==2017 ESC Guideline for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death<ref name="Al-KhatibStevenson2018">{{cite journal|last1=Al-Khatib|first1=Sana M.|last2=Stevenson|first2=William G.|last3=Ackerman|first3=Michael J.|last4=Bryant|first4=William J.|last5=Callans|first5=David J.|last6=Curtis|first6=Anne B.|last7=Deal|first7=Barbara J.|last8=Dickfeld|first8=Timm|last9=Field|first9=Michael E.|last10=Fonarow|first10=Gregg C.|last11=Gillis|first11=Anne M.|last12=Granger|first12=Christopher B.|last13=Hammill|first13=Stephen C.|last14=Hlatky|first14=Mark A.|last15=Joglar|first15=José A.|last16=Kay|first16=G. Neal|last17=Matlock|first17=Daniel D.|last18=Myerburg|first18=Robert J.|last19=Page|first19=Richard L.|title=2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death|journal=Circulation|volume=138|issue=13|year=2018|issn=0009-7322|doi=10.1161/CIR.0000000000000549}}</ref>==
==


{|class="wikitable"
{|class="wikitable"
Line 54: Line 53:
| colspan="1" style="text-align:center; background:LightGreen"|[[ACC AHA Guidelines Classification Scheme#Classification of Recommendations|Class I]]
| colspan="1" style="text-align:center; background:LightGreen"|[[ACC AHA Guidelines Classification Scheme#Classification of Recommendations|Class I]]
|-
|-
| bgcolor="LightGreen"| <nowiki></nowiki> '''1.''' It is recommended that [[patients]] with a life-threatening presentation of [[Sustained ventricular tachycardia|sustained ventricular tachyarrhythmias]] in the context of clinically suspected myocarditis are referred to specialized centers with the ability to perform [[hemodynamic]] monitoring, [[cardiac catheterization]] and [[endomyocardial biopsy]] and to use mechanical [[cardio]]-[[pulmonary]] assist devices and specialized [[arrhythmia]] [[Therapy|therapies]]. ''([[ACC AHA Guidelines Classification Scheme#Level of Evidence|Level of Evidence: C]])''<ref name="CaforioPankuweit2013">{{cite journal|last1=Caforio|first1=A. L. P.|last2=Pankuweit|first2=S.|last3=Arbustini|first3=E.|last4=Basso|first4=C.|last5=Gimeno-Blanes|first5=J.|last6=Felix|first6=S. B.|last7=Fu|first7=M.|last8=Helio|first8=T.|last9=Heymans|first9=S.|last10=Jahns|first10=R.|last11=Klingel|first11=K.|last12=Linhart|first12=A.|last13=Maisch|first13=B.|last14=McKenna|first14=W.|last15=Mogensen|first15=J.|last16=Pinto|first16=Y. M.|last17=Ristic|first17=A.|last18=Schultheiss|first18=H.-P.|last19=Seggewiss|first19=H.|last20=Tavazzi|first20=L.|last21=Thiene|first21=G.|last22=Yilmaz|first22=A.|last23=Charron|first23=P.|last24=Elliott|first24=P. M.|title=Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases|journal=European Heart Journal|volume=34|issue=33|year=2013|pages=2636–2648|issn=0195-668X|doi=10.1093/eurheartj/eht210}}</ref><ref>{{Cite journal
| bgcolor="LightGreen"| <nowiki></nowiki> '''1.''' Patients presenting with syncope for which VA is documented, or thought to be a likely cause, should be hospitalized for evaluation, monitoring, and management''([[ACC AHA Guidelines Classification Scheme#Level of Evidence|Level of Evidence: B-NR]])''.<ref name="BrugadaBrugada1991">{{cite journal|last1=Brugada|first1=P|last2=Brugada|first2=J|last3=Mont|first3=L|last4=Smeets|first4=J|last5=Andries|first5=E W|title=A new approach to the differential diagnosis of a regular tachycardia with a wide QRS complex.|journal=Circulation|volume=83|issue=5|year=1991|pages=1649–1659|issn=0009-7322|doi=10.1161/01.CIR.83.5.1649}}</ref>
| title = Guidelines for diagnosis and treatment of myocarditis (JCS 2009): digest version
<ref name="ElhendyChandrasekaran2002">{{cite journal|last1=Elhendy|first1=Abdou|last2=Chandrasekaran|first2=Krishnaswamy|last3=Gersh|first3=Bernard J|last4=Mahoney|first4=Douglas|last5=Burger|first5=Kelli N|last6=Pellikka|first6=Patricia A|title=Functional and prognostic significance of exercise-induced ventricular arrhythmias in patients with suspected coronary artery disease|journal=The American Journal of Cardiology|volume=90|issue=2|year=2002|pages=95–100|issn=00029149|doi=10.1016/S0002-9149(02)02428-1}}</ref>
| journal = [[Circulation journal : official journal of the Japanese Circulation Society]]
<nowiki></nowiki>
| volume = 75
| issue = 3
| pages = 734–743
| year = 2011
| month =
| doi = 10.1253/circj.cj-88-0008
| pmid = 21304213
}}</ref><ref>{{Cite journal
| author = [[Naoyoshi Aoyama]], [[Tohru Izumi]], [[Katsuhiko Hiramori]], [[Mitsuaki Isobe]], [[Masatoshi Kawana]], [[Michiaki Hiroe]], [[Hitoshi Hishida]], [[Yasushi Kitaura]] & [[Tsutomu Imaizumi]]
| title = National survey of fulminant myocarditis in Japan: therapeutic guidelines and long-term prognosis of using percutaneous cardiopulmonary support for fulminant myocarditis (special report from a scientific committee)
| journal = [[Circulation journal : official journal of the Japanese Circulation Society]]
| volume = 66
| issue = 2
| pages = 133–144
| year = 2002
| month = February
| doi = 10.1253/circj.66.133
| pmid = 11999637
}}</ref><ref name="LibermanAnderson2014">{{cite journal|last1=Liberman|first1=Leonardo|last2=Anderson|first2=Brett|last3=Silver|first3=Eric S.|last4=Singh|first4=Rakesh|last5=Richmond|first5=Marc E.|title=INCIDENCE AND CHARACTERISTICS OF ARRHYTHMIAS IN PEDIATRIC PATIENTS WITH MYOCARDITIS: A MULTICENTER STUDY|journal=Journal of the American College of Cardiology|volume=63|issue=12|year=2014|pages=A483|issn=07351097|doi=10.1016/S0735-1097(14)60483-6}}</ref><nowiki></nowiki>
|-
|-
| bgcolor="LightGreen"| <nowiki></nowiki> '''2.''' [[Temporary cardiac pacing|Temporary pacemaker]] [[insertion]] is recommended in [[patients]] with [[bradycardia]] and/or [[heart block]] triggering VA during the [[acute]] phase of myocarditis/pancarditis.''([[ACC AHA Guidelines Classification Scheme#Level of Evidence|Level of Evidence: C]])<ref name="CaforioPankuweit2013">{{cite journal|last1=Caforio|first1=A. L. P.|last2=Pankuweit|first2=S.|last3=Arbustini|first3=E.|last4=Basso|first4=C.|last5=Gimeno-Blanes|first5=J.|last6=Felix|first6=S. B.|last7=Fu|first7=M.|last8=Helio|first8=T.|last9=Heymans|first9=S.|last10=Jahns|first10=R.|last11=Klingel|first11=K.|last12=Linhart|first12=A.|last13=Maisch|first13=B.|last14=McKenna|first14=W.|last15=Mogensen|first15=J.|last16=Pinto|first16=Y. M.|last17=Ristic|first17=A.|last18=Schultheiss|first18=H.-P.|last19=Seggewiss|first19=H.|last20=Tavazzi|first20=L.|last21=Thiene|first21=G.|last22=Yilmaz|first22=A.|last23=Charron|first23=P.|last24=Elliott|first24=P. M.|title=Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases|journal=European Heart Journal|volume=34|issue=33|year=2013|pages=2636–2648|issn=0195-668X|doi=10.1093/eurheartj/eht210}}</ref><ref>{{Cite journal
| title = Guidelines for diagnosis and treatment of myocarditis (JCS 2009): digest version
| journal = [[Circulation journal : official journal of the Japanese Circulation Society]]
| volume = 75
| issue = 3
| pages = 734–743
| year = 2011
| month =
| doi = 10.1253/circj.cj-88-0008
| pmid = 21304213
}}</ref>''<nowiki></nowiki>
|}
|}


Revision as of 22:36, 15 April 2020

Premature ventricular contraction Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Premature Ventricular Contraction from other Disorders

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Premature ventricular contraction history and symptoms On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Premature ventricular contraction history and symptoms

CDC onPremature ventricular contraction history and symptoms

Premature ventricular contraction history and symptoms in the news

Blogs on Premature ventricular contraction history and symptoms

to Hospitals Treating Premature ventricular contraction history and symptoms

Risk calculators and risk factors for Premature ventricular contraction history and symptoms

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mugilan Poongkunran M.B.B.S [2]

Overview

Premature ventricular contraction patients may have no symptom at all or may present with exercise intolerance and chest pain. Sometimes patients may present with a non specific feeling of forceful beat which might need the use of Holter monitor to pick up PVCs.

History and Symptoms

Although there are many signs and symptoms associated with PVCs, PVCs may have no symptom at all. An isolated PVC is hard to catch without the use of a Holter monitor. PVCs may be perceived as a skipped heart beat, a strong beat, or a feeling of suction in the chest. They may also cause chest pain, a faint feeling, fatigue, or hyperventilation after exercise. Several PVCs in a row becomes a form of ventricular tachycardia (VT), which is a potentially fatal cardiac arrhythmia.

Some other possible symptoms of PVCs:

  • Shortness of breath
  • Dizziness
  • Feeling your heart beat (palpitations)
  • Feeling of occasional, forceful beats
  • Increased awareness of your heart beat

Overview

The majority of patients with [disease name] are asymptomatic.

OR

The hallmark of [disease name] is [finding]. A positive history of [finding 1] and [finding 2] is suggestive of [disease name]. The most common symptoms of [disease name] include [symptom 1], [symptom 2], and [symptom 3]. Common symptoms of [disease] include [symptom 1], [symptom 2], and [symptom 3]. Less common symptoms of [disease name] include [symptom 1], [symptom 2], and [symptom 3].

History and Symptoms

  • The majority of patients with PVC are asymptomatic.

History

Patients with [disease name]] may have a positive history of:

  • [History finding 1]
  • [History finding 2]
  • [History finding 3]

Common Symptoms

Common symptoms of PVCs include:

  • Irregular heart beats sensation (skipped heart beat, a strong beat, or a feeling of suction in the chest)
  • Dizziness
  • Chest pain
  • Faint
  • Fatigue
  • Other symptoms of heart failure

Less Common Symptoms

Less common symptoms of [disease name] include

  • Syncope
  • Hypotension

2017 ESC Guideline for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death[1]

Class I
1. Patients presenting with syncope for which VA is documented, or thought to be a likely cause, should be hospitalized for evaluation, monitoring, and management(Level of Evidence: B-NR).[2]

[3]

References

  1. ↑ Al-Khatib, Sana M.; Stevenson, William G.; Ackerman, Michael J.; Bryant, William J.; Callans, David J.; Curtis, Anne B.; Deal, Barbara J.; Dickfeld, Timm; Field, Michael E.; Fonarow, Gregg C.; Gillis, Anne M.; Granger, Christopher B.; Hammill, Stephen C.; Hlatky, Mark A.; Joglar, José A.; Kay, G. Neal; Matlock, Daniel D.; Myerburg, Robert J.; Page, Richard L. (2018). "2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death". Circulation. 138 (13). doi:10.1161/CIR.0000000000000549. ISSN 0009-7322.
  2. ↑ Brugada, P; Brugada, J; Mont, L; Smeets, J; Andries, E W (1991). "A new approach to the differential diagnosis of a regular tachycardia with a wide QRS complex". Circulation. 83 (5): 1649–1659. doi:10.1161/01.CIR.83.5.1649. ISSN 0009-7322.
  3. ↑ Elhendy, Abdou; Chandrasekaran, Krishnaswamy; Gersh, Bernard J; Mahoney, Douglas; Burger, Kelli N; Pellikka, Patricia A (2002). "Functional and prognostic significance of exercise-induced ventricular arrhythmias in patients with suspected coronary artery disease". The American Journal of Cardiology. 90 (2): 95–100. doi:10.1016/S0002-9149(02)02428-1. ISSN 0002-9149.

Template:WH Template:WS

Retrieved from "https://www.wikidoc.org/index.php?title=Premature_ventricular_contraction_history_and_symptoms&oldid=1604990"